Amicus Therapeutics, Inc. (FOLD) Social Stream



Amicus Therapeutics, Inc. (FOLD): $11.21

0.13 (+1.17%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FOLD to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

AMICUS THERAPEUTICS INC (FOLD) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering FOLD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 11 $29 $12 $18.333 $11.2 63.69%
2021-11-15 10 $29 $12 $18.444 $11.2 64.68%
2021-11-23 10 $29 $12 $18.555 $11.2 65.67%
2022-01-13 9 $29 $12 $17.375 $11.2 55.13%
2022-01-17 9 $29 $15 $17.875 $11.2 59.6%
2022-01-26 9 $29 $15 $17.5 $11.2 56.25%
2022-02-25 9 $29 $14 $17 $11.2 51.79%
2022-04-20 9 $20 $14 $15.5 $11.2 38.39%
2022-05-10 10 $20 $11 $15 $11.2 33.93%
2022-05-12 10 $20 $11 $15.222 $11.2 35.91%
2022-08-05 7 $20 $11 $15.285 $11.2 36.47%
2022-08-13 7 $20 $11 $15.142 $11.2 35.2%
2022-10-19 8 $20 $11 $15 $11.2 33.93%
2022-11-07 8 $20 $11 $15.125 $11.2 35.04%
2022-11-15 8 $20 $11 $15.428 $11.2 37.75%
2023-01-16 8 $20 $11 $15.375 $11.2 37.28%
2023-02-08 8 $20 $11 $15.875 $11.2 41.74%
2023-03-03 9 $20 $11 $16.111 $11.2 43.85%

The Trend in the Analyst Price Target


Over the past 16 months, FOLD's average price target has gone down $2.22.

Over the past 45 weeks, FOLD's average upside potential has been 52.07%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-20 9 20 14 15.500 8.26 87.65%
2022-09-17 8 20 11 15.000 10.62 41.24%
2023-01-10 8 20 11 15.375 11.45 34.28%
2023-01-16 8 20 11 15.375 12.83 19.84%
2023-01-16 8 20 11 15.875 12.83 23.73%

FOLD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.44 7 0 2 0 0 9

The Trend in the Broker Recommendations


Over the past 43 weeks, FOLD's average broker recommendation rating worsened by 0.04.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, AMICUS THERAPEUTICS INC's average analyst price target is higher than 459.61% of them.
  • In terms of how AMICUS THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1597.83% of that group.
  • In terms of how AMICUS THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 533.51% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's number of analysts covering the stock is higher than 1556.63% of them.

In the Pharmaceutical Products industry, ENTA, MDGL, and MGNX are the three stocks most similar to AMICUS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is FOLD a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8408 seconds.